계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Enzypep
company
About
Enzypep designs and develops oligopeptides for pharmaceutical products.
- 1 - 10
Highlights
Details
- Last Funding Type
- Funding Round
- Industries
- Biotechnology,Genetics,Health Care,Life Science,Manufacturing
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Enzypep designs and develops oligopeptides for pharmaceutical products. The Enzypep technology is expected to become the state-of-the-art in design and preparation of complex peptides. Compared with standard synthesis it results in pharmaceutical products with a much higher purity, at a much lower cost and in a sustainable, environmentally-friendly manner. It began operation in 2012, with its headquarters in Geleen in the Netherlands.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Enzypep has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2014 from a Funding Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2014 | Funding Round | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Enzypep is funded by 2 investors.
Nedermaas Hightech Ventures
and Limburg Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Nedermaas Hightech Ventures
|
— | Funding Round |
Limburg Ventures
|
— | Funding Round |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
